Bee Venom Acupuncture for Neck Pain: A Review of the Korean Literature
Soo-Hyun Sung,
Hee-Jung Lee,
Ji-Eun Han,
Angela Dong-Min Sung,
Minjung Park,
Seungwon Shin,
Hye In Jeong,
Soobin Jang,
Gihyun Lee
Affiliations
Soo-Hyun Sung
Department of Policy Development, National Institute of Korean Medicine Development, Seoul 04554, Republic of Korea
Hee-Jung Lee
Department of Policy Development, National Institute of Korean Medicine Development, Seoul 04554, Republic of Korea
Ji-Eun Han
Department of Policy Development, National Institute of Korean Medicine Development, Seoul 04554, Republic of Korea
Angela Dong-Min Sung
Department of Policy Development, National Institute of Korean Medicine Development, Seoul 04554, Republic of Korea
Minjung Park
Center for Development of Innovative Technologies in Korean Medicine, National Institute of Korean Medicine Development, Seoul 04554, Republic of Korea
Seungwon Shin
Department of Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea
Hye In Jeong
Department of Preventive Medicine, College of Korean Medicine, Kyung Hee University, Seoul 02447, Republic of Korea
Soobin Jang
Department of Preventive Medicine, College of Korean Medicine, Daegu Haany University, Gyeongsan 38609, Republic of Korea
Gihyun Lee
College of Korean Medicine, Dongshin University, Naju 58245, Republic of Korea
Bee venom is a natural toxin that is effective in treating various types of pain. The purpose of this paper was to review all the features of clinical studies conducted on bee venom acupuncture (BVA) for the treatment of neck pain in Korean publications. Six Korean databases and 16 Korean journals were searched in August 2022 for clinical studies on BVA for neck pain. We identified 24 trials that met our inclusion criteria, of which 316 patients with neck pain were treated with BVA. The most common diagnosis in the patients with neck pain was herniated intervertebral discs (HIVDs) of the cervical spine (C-spine) (29.2%), and the concentration and dosage per session were 0.05–0.5 mg/mL and 0.1–1.5 mL, respectively. The visual analog scale was most often measured for neck pain severity (62.5%), and all clinical research reported improvements in 16 outcome measures. This study shows that BVA could be recommended for the treatment of neck pain, especially HIVD of the C-spine; however, the adverse effects of BVA must be examined in future studies.